KalVista Pharmaceuticals, Inc. (KALV)

16.06 -0.22 (-1.35%) USD  |  NASDAQ  |  Mar 02, 16:00
15.70 -0.36 (-2.24%) Pre-Market: 08:43
More

KalVista Pharmaceuticals Stock Based Compensation (Annual Per Share)

Stock Based Compensation (Annual Per Share) Chart

View Stock Based Compensation (Annual Per Share) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual Per Share) Range, Past 5 Years

View Stock Based Compensation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual Per Share) Benchmarks

View Stock Based Compensation (Annual Per Share) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Modular Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade